Search

You searched for "entropion"

682 results found

Sensitive cilia – eyelashes in health and disease

5 October 2020 | | Ophthalmology, Optometry, Cornea / External Eye Disease, Orbit, Oculoplastics
In health our eyelashes protect the eyes, but in disease they can disfigure, impair quality of life and threaten vision. In this review the authors discuss aspects of lashes that are relevant to all professionals working near the eyes and...

Code-Free Deep Learning: a step into the future of ophthalmology

3 October 2022 | | Ophthalmology
A new focus has arisen within the research domain of artificial intelligence (AI) in healthcare called code-free deep learning (CFDL), and recent research demonstrates that ophthalmology is becoming one of the leading specialties in this field. Artificial intelligence (AI) is...

RCOphth 2024 Report

28 May 2024 | EyeConUK, RCOphth2024, Royal College of Ophthalmology, events, meetings, reports, previews, Eye News
A comprehensive tapestry of all our RCOphth Annual Congress content captured between 20–23 May 2024.

Immunoglobulin G4-related ophthalmic disease – what is it? (Part 2)

3 April 2023 |
Part 2: Clinical presentation and treatment (see part 1 here) Introduction IgG4-related disease (IgG4-RD) is understood to have a vast clinicopathological spectrum; nearly every organ has had reported involvement. Similarly, IgG4-related ophthalmic disease (IgG4-ROD) is known to affect nearly every...

Eye research: where next?

1 December 2017 | | Cornea / External Eye Disease, Cataract and Refractive, Glaucoma, Genetics, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous, AMD, Emergency Ophthalmology
Eye research in the UK is underfunded relative to other areas of medical research and general awareness of sight loss and its prevention remains poor, messages that were reinforced in presentations and discussions during a recent research summit meeting in...

Pathophysiology of diabetic macular oedema: why combination therapy may be better

1 October 2015 | | Retina / Uvea / Vitreous
The prevalence of diabetes has continued to increase over the years. It is currently estimated that there are 382 million with diabetes worldwide in 2013, and that this figure is expected to rise to 592 million by 2035 [1]. In...

Designing ophthalmology services Part 3: How do we address the queues post‑COVID-19?

5 August 2020 | | Ophthalmology, Cataract and Refractive, Retina / Uvea / Vitreous
Part 1 of this series available herePart 2 of this series available here There is going to be enormous demand on ophthalmology services as they start to welcome patients back. The authors explain how modelling can help make the most...

The Real Top Gun: Professor Steve Schallhorn

3 April 2023 | | Ophthalmology
Steve Schallhorn: Fighter Pilot. In the spring of 1987, I travelled to the cinema at Hendon Central in London with some school friends to watch the newly released movie The Witches of Eastwick starring Jack Nicholson and Michelle Pfeiffer. Unfortunately...

The International Centre for Eye Health: weaving the global threads together

4 October 2023 | | Ophthalmology
The VISION 2020 LINKS & Networks Programme has been writing regular articles in Eye News about its capacity-strengthening activities in low- and middle-income countries (LMICs) for more than a decade. This, the first International Issue, is a landmark for Eye...

Update on emerging therapies for age-related macular degeneration

4 December 2023 | | AMD
The 23rd European Society of Retina Specialists (EURETINA) Congress, held in Amsterdam, the Netherlands, provided a timely update on anti-complement therapy for geographic atrophy and emerging investigational therapies for neovascular age-related macular degeneration. Anti-complement therapy for geographic atrophy Geographic atrophy...